Immunic Therapeutics

🇺🇸 Happy 4th of July from all of us at Immunic! 🎆 🎉 Wishing everyone a safe and joyous Independence Day filled with celebration, gratitude, and togetherness. 🎇 #4thOfJuly #FourthOfJuly #July4th #IndependenceDay #IMUX #Immunic

💡 Discover TipRanks reporter Sheryl Sheth's deep dive into Immunic's lead program aimed at treating relapsing and progressive forms of multiple sclerosis. Vidofludimus calcium has already shown signs of neuroprotective, anti-inflammatory, and anti-viral effects in clinical testing and is currently being investigated in phase 3 and phase 2 trials. Do you want to learn more? Read the full article here: ➡️ https://bit.ly/3xyv8k6 #MultipleSclerosis #MS #RMS #PMS #Neurology #Immunic #IMUX #Vidofludimus

💡Check out this in-depth interview with Dr. Daniel Vitt, CEO and President of Immunic, featured in Euro Health Leaders. Dr. Vitt shares valuable insights on his personal journey in the biotechnology space, Immunic's research and development pipeline, and what’s next in the field of multiple sclerosis. Read the full interview here: ➡️ https://bit.ly/4b8CWqu #EuroHealthLeaders #BiotechLeadership #HealthcareInnovation #biotechnology #biotech #MultipleSclerosis #MS #Immunic #IMUX

🌾 Join us for an insightful webinar hosted by the Society for the Study of Celiac Disease on "Hot Topics from Digestive Disease Week." 👩🔬 This event features leading experts, including our Senior Medical Director, Franziska Buriánek, MD, discussing latest research, steps towards a potential treatment, and emerging trends in celiac disease and related gastrointestinal disorders. Immunic's research is presented by Vahe Badalyan, MD, Assistant Professor, Children's National Hospital and focuses on our first-in-human trial of IMU-856, an orally available epigenetic modulator of barrier regeneration for the treatment of celiac disease (minute 38). ▶️ https://bit.ly/3xMapJv #Celiac #CeliacDisease #Immunic #IMUX #IMU856 #SSCD #DigestiveDiseaseWeek #DDW #DDW2024 #gastrointestinal #gastroenterology

📺 Don't miss the latest Proactive video featuring Dr. Daniel Vitt, CEO and President of Immunic, as he dives into crucial questions and insights about autoimmune diseases and the future of multiple sclerosis treatment. 🧠 ➡️ https://bit.ly/3KZIby5 #immunology #AutoimmuneDiseases #MSResearch #MultipleSclerosis #MS #RRMS #RMS #PMS #Vidofludimus #Immunic #IMUX

🌾 Celiac disease is not an allergy or a sensitivity to gluten! It's a serious, lifelong autoimmune disorder! Currently, the only treatment is a strict gluten-free diet. "But that urgently needs to change," stresses our Chief Scientific Officer, Dr. Hella Kohlhof. She shares valuable insights on the disease and our ongoing research and development efforts in this Proactive video: ➡️ https://bit.ly/3wIb7Hu. 💙 #Celiac #CeliacDisease #CeliacDiseaseAwareness #Gluten #GlutenFree #IMU856 #Immunic #IMUX Celiac Disease Foundation, Beyond Celiac

🙏✨ We appreciate that our Chief Medical Officer, Dr. Andreas Muehler, had the opportunity to attend the exclusive Financial Times roundtable event in #London yesterday! 🌍 Dr. Muehler had inspiring conversations with colleagues from around the globe about innovative #business models for the successful #MarketEntry of European companies into the US market. 🚀 #FinancialTimes #Immunic #IMUX #Biotechnology #Biotech #Biopharma #Innovation #Commercialization #MarketEntry #Financing #Business

✨ We are excited to announce that our Chief Medical Officer, Dr. Andreas Muehler, will be participating in an exclusive roundtable event today at the Financial Times headquarters in #London. 🤝 The private discussion, chaired by a Financial Times journalist, will bring together carefully selected executives to explore: ☑ Opportunities and risks associated with commercialising in the U.S. ☑ Strategies for navigating the U.S. regulatory system ☑ Effective business and funding models for successful market entry #FinancialTimes #Biotechnology #Biotech #Biopharma #Commercialisation #HealthcareInnovation #Immunic #IMUX

✨ Happy Juneteenth! ✨ At Immunic, we honor #Juneteenth, a pivotal day in American history marking the end of slavery and the enduring fight for freedom and equality. We are committed to fostering a diverse and inclusive environment where innovation thrives through the unique perspectives and contributions of all our team members. ✊🏻✊🏽✊🏾✊🏿 #Immunic #IMUX #Innovation #InclusionMatters #CelebrateFreedom

📽️ Our CEO & President, Dr. Daniel Vitt, shares insights on the extended data from our phase 2 EMPhASIS trial of vidofludimus calcium in relapsing-remitting multiple sclerosis in this Proactive interview. The findings are featured in a peer-reviewed article recently published in Neurology® Neuroimmunology & Neuroinflammation, the official journal of the American Academy of Neurology. Don’t miss it! 🧠 ▶️ https://bit.ly/4dmr8De #Immunic #IMUX #vidofludimus #IMU838 #EMPhASIS #ClinicalTrials #neurofilament #NfL #RRMS #MS #MultipleSclerosis #MSResearch #Neurology #SciencePublication